Literature DB >> 1596199

Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients.

M Ramos-Kuri1, R M Montoya, A Padilla, T Govezensky, M L Díaz, E Sciutto, J Sotelo, C Larralde.   

Abstract

To ascertain the reliability of serological diagnosis of neurocysticercosis in the everyday a priori situation of neurological consultation, the enzyme-linked immunosorbent assay test was used to predict the eventual diagnosis of neurocysticercosis in an unselected sample of 1064 consecutive neurological cases. Results showed 69% sensitivity and 71% specificity of the enzyme-linked immunosorbent assay test for the diagnosis of neurocysticercosis. In sharp contrast with publications that have proclaimed the excellent diagnostic performance of immunodiagnostic tests, our results suggest that identification of serum antibodies with standard enzyme-linked immunosorbent assay techniques is of little value when applied to a large and heterogeneous group of neurological patients in an endemic area of cysticercosis, and our results urge a reevaluation of currently used immunodiagnostic tests that are practiced in the serum of suspected cases.

Entities:  

Mesh:

Year:  1992        PMID: 1596199     DOI: 10.1001/archneur.1992.00530300069012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  25 in total

1.  Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.

Authors:  A Toledo; C Larralde; G Fragoso; G Gevorkian; K Manoutcharian; M Hernández; G Acero; G Rosas; F López-Casillas; C K Garfias; R Vázquez; I Terrazas; E Sciutto
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Multicystic tumor in the fourth ventricle: consider neurocysticercosis.

Authors:  Clarissa U Prazeres da Costa; Helga Gräfin von Einsiedel; Rüdiger Disko; Achim Berthele
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

Review 3.  Parasitic infections and myositis.

Authors:  Samar N El-Beshbishi; Nairmen N Ahmed; Samar H Mostafa; Goman A El-Ganainy
Journal:  Parasitol Res       Date:  2011-09-01       Impact factor: 2.289

Review 4.  Neurocysticercosis and epilepsy in developing countries.

Authors:  D K Pal; A Carpio; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

5.  Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci.

Authors:  K Hubert; A Andriantsimahavandy; A Michault; M Frosch; F A Mühlschlegel
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

6.  A profile of childhood neurocysticercosis.

Authors:  V Kalra; M Suri; B L Jailkhani
Journal:  Indian J Pediatr       Date:  1994 Jan-Feb       Impact factor: 1.967

7.  An uncommon cause of seizures in children living in developed countries: neurocysticercosis--a case report.

Authors:  Irene Raffaldi; Carlo Scolfaro; Federica Mignone; Sonia Aguzzi; Federica Denegri; Pier-Angelo Tovo
Journal:  Ital J Pediatr       Date:  2011-01-25       Impact factor: 2.638

8.  Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.

Authors:  Juliya Kalinina; Jun Ahn; Narra S Devi; Liya Wang; Yuancheng Li; Jeffrey J Olson; Michael Glantz; Thomas Smith; Ella L Kim; Alf Giese; Randy L Jensen; Clark C Chen; Bob S Carter; Hui Mao; Miao He; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2016-06-23       Impact factor: 12.531

Review 9.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Antigens from Taenia crassiceps cysticerci used in complement fixation, enzyme-linked immunosorbent assay, and western blot (immunoblot) for diagnosis of neurocysticercosis.

Authors:  E Garcia; G Ordoñez; J Sotelo
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.